Mailing Vaginal or Urine Self-Sampling Kits versus Conventional Invitation Letters: A Randomized Trial to Assess the Effect on Cervical Cancer Screening Attendance
There is evidence that sending VSS kits can increase attendance at cervical cancer screening. However, no data exist suggesting that sending urine collection kits may also be effective in triggering participation compared with conventional invitation letters. The results of the CapU4 trial may generate innovative tools that could help optimize attendance at cervical cancer screening.
Authors
- Alexandra Ducancelle (ORCID: https://orcid.org/0000-0003-3173-8000)
- Franck Rexand-Galais (ORCID: https://orcid.org/0000-0002-6044-3933)
- Caroline Lefeuvre (ORCID: https://orcid.org/0000-0003-4934-5926)
- Hélène De Pauw (ORCID: https://orcid.org/0000-0003-3327-027X)
- Marc Arbyn (ORCID: https://orcid.org/0000-0001-7807-5908)
- Johane Le Goff (ORCID: https://orcid.org/0009-0003-4063-3320)
- Adeline Pivert (ORCID: https://orcid.org/0000-0002-8109-7881)
- Anne-Sophie Le Duc-Banaszuk (ORCID: https://orcid.org/0000-0001-9367-823X)
- Micheline Boudet (ORCID: https://orcid.org/0009-0007-7690-6908)
- Aline Lebon (ORCID: https://orcid.org/0009-0007-1154-1282)
- Nina Dhollander
Institutions
- University of Antwerp (BE)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Ghent University (BE)
- Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR)
- Services déconcentrés d'appui à la recherche Pays de la Loire (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Sciensano (Belgium) (BE)
- Université Toulouse - Jean Jaurès (FR)
- Université d'Angers (FR)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-0863
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Deutsche Krebshilfe
- Institut National Du Cancer
- Horizon 2020 Framework Programme
- National Cancer Institute